Three midlife risks tied to much earlier dementia onset

Clinical takeaway: Discussing vascular risks before age 60 offers a concrete way to talk about brain health. But much of the advantage may simply come from living longer, not from avoiding dementia altogether.

Blood pressure, glucose, and smoking status all sit on the same midlife problem list, each with its own target and its own 10-year cardiovascular risk estimate attached. But cognition has no equivalent. Patients in their 50s often ask about how to protect brain health, and the honest answer so far has been that vascular care probably helps.

About 42% of middle-aged US adults will develop dementia at some point, and the drugs now available reach only early disease. That leaves midlife risk factor control as a practical lever, though the case for it has mostly been argued in relative risk, which is hard to translate in a visit. A prospective cohort study attempts to quantify this, tracking three primary risk factors from midlife into late life and measuring how long people stayed cognitively intact.

Adults who reached midlife with none of the three vascular risk factors, hypertension, diabetes, and current smoking, lived an average of 30.1 years without dementia from age 55, compared with 17.5 years for those carrying all three. The gradient was stepwise, at 26.3 years with one risk factor and 21.0 years with two.

Dementia arrived earlier with a higher risk count, reaching 10% cumulative incidence by age 75 with all three factors against 3% with none. But the steeper divide was mortality: 53% of the three-factor group had died dementia-free by 75, compared with 10% of the zero-factor group. Women and Black participants diverged too, with women holding more dementia-free years at every risk level and Black participants fewer. Black participants made up 25% of the cohort but 60% of the group carrying all three risk factors.

The cohort was composed of 12,409 adults from four US communities, dementia-free and averaging 56 years old at a 1990-1992 baseline visit, then followed a median of 26 years. Hypertension was defined as BP of 140/90 mm Hg or higher or use of BP-lowering medication, and diabetes as self-report, medication use, or an A1c of 6.5% or higher. Dementia was adjudicated by an expert panel drawing on repeat cognitive testing, informant interviews, and records surveillance through 2022.

The research question is whether treating these factors after midlife wins any of those years back. This study measured each patient's risks once, so it cannot say, and answering it takes a design that follows the same people.

"These results suggest that vascular risk reduction may benefit all groups, but that certain populations, such as Black adults, may especially benefit from targeted prevention efforts," said Josef Coresh, MD, PhD, founding director of the Optimal Aging Institute at NYU Langone Health.

Source: Hu J, et al. (2026 Aug 5). Neurol Open Access. Midlife Vascular Risk Burden and Dementia-Free Survival Years: The Atherosclerosis Risk in Communities Neurocognitive Study